HIF3A
Basic information
Region (hg38): 19:46297042-46343433
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HIF3A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 2 | |||||
missense | 75 | 82 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 1 | 2 | 3 | |||
non coding | 0 | |||||
Total | 0 | 0 | 75 | 8 | 1 |
Variants in HIF3A
This is a list of pathogenic ClinVar variants found in the HIF3A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
19-46297093-A-G | not specified | Uncertain significance (May 30, 2024) | ||
19-46303900-C-G | not specified | Uncertain significance (Dec 16, 2023) | ||
19-46303949-G-A | not specified | Likely benign (Nov 21, 2023) | ||
19-46304040-A-G | not specified | Uncertain significance (Mar 25, 2024) | ||
19-46304057-C-T | not specified | Likely benign (Mar 20, 2024) | ||
19-46304073-C-T | not specified | Uncertain significance (Nov 30, 2021) | ||
19-46304074-G-A | not specified | Uncertain significance (Oct 06, 2022) | ||
19-46305262-G-A | not specified | Uncertain significance (Jun 30, 2022) | ||
19-46305272-G-C | not specified | Uncertain significance (Nov 26, 2024) | ||
19-46305334-G-A | not specified | Uncertain significance (Oct 03, 2022) | ||
19-46305343-A-G | not specified | Uncertain significance (Nov 13, 2024) | ||
19-46305359-A-G | not specified | Uncertain significance (Jul 19, 2023) | ||
19-46305382-C-T | not specified | Uncertain significance (Sep 09, 2024) | ||
19-46308231-T-C | not specified | Uncertain significance (Mar 23, 2022) | ||
19-46308299-C-G | not specified | Uncertain significance (Oct 26, 2022) | ||
19-46308302-C-A | not specified | Uncertain significance (Dec 20, 2021) | ||
19-46308683-G-A | not specified | Uncertain significance (Sep 20, 2023) | ||
19-46308697-G-T | not specified | Uncertain significance (Feb 27, 2024) | ||
19-46308714-G-A | not specified | Uncertain significance (Jan 09, 2024) | ||
19-46308740-G-A | not specified | Uncertain significance (Jan 30, 2024) | ||
19-46308744-G-A | not specified | Uncertain significance (Feb 05, 2024) | ||
19-46308755-C-G | not specified | Uncertain significance (Aug 30, 2021) | ||
19-46309151-G-T | not specified | Uncertain significance (Aug 04, 2024) | ||
19-46309153-G-A | Likely benign (Mar 30, 2018) | |||
19-46309205-C-T | not specified | Uncertain significance (Dec 12, 2022) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HIF3A | protein_coding | protein_coding | ENST00000377670 | 15 | 46388 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00154 | 0.998 | 125715 | 0 | 33 | 125748 | 0.000131 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.757 | 370 | 413 | 0.895 | 0.0000255 | 4252 |
Missense in Polyphen | 126 | 179.1 | 0.70352 | 1798 | ||
Synonymous | -0.200 | 182 | 179 | 1.02 | 0.0000116 | 1427 |
Loss of Function | 3.19 | 10 | 28.3 | 0.353 | 0.00000129 | 333 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000345 | 0.000345 |
Ashkenazi Jewish | 0.000101 | 0.0000992 |
East Asian | 0.000218 | 0.000217 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000144 | 0.000141 |
Middle Eastern | 0.000218 | 0.000217 |
South Asian | 0.000133 | 0.000131 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Acts as a transcriptional regulator in adaptive response to low oxygen tension. Acts as a regulator of hypoxia-inducible gene expression (PubMed:11573933, PubMed:16126907, PubMed:19694616, PubMed:20416395, PubMed:21069422). Functions as an inhibitor of angiogenesis in hypoxic cells of the cornea. Plays a role in the development of the cardiorespiratory system. May also be involved in apoptosis (By similarity). {ECO:0000250|UniProtKB:Q0VBL6, ECO:0000269|PubMed:11573933, ECO:0000269|PubMed:16126907, ECO:0000269|PubMed:19694616, ECO:0000269|PubMed:20416395, ECO:0000269|PubMed:21069422}.; FUNCTION: Isoform 3: Attenuates the ability of transcription factor HIF1A to bind to hypoxia-responsive elements (HRE) located within the enhancer/promoter of hypoxia-inducible target genes and hence inhibits HRE-driven transcriptional activation. {ECO:0000269|PubMed:19694616, ECO:0000269|PubMed:20416395, ECO:0000269|PubMed:21069422}.; FUNCTION: Isoform 5: Attenuates the ability of transcription factor HIF1A to bind to hypoxia-responsive elements (HRE) located within the enhancer/promoter of hypoxia-inducible target genes and hence inhibits HRE-driven transcriptional activation. {ECO:0000269|PubMed:21069422}.;
- Pathway
- Focal Adhesion-PI3K-Akt-mTOR-signaling pathway;Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha;Regulation of gene expression by Hypoxia-inducible Factor;Regulation of Hypoxia-inducible Factor (HIF) by oxygen;Cellular response to hypoxia;Cellular responses to stress;Post-translational protein modification;Metabolism of proteins;Hypoxic and oxygen homeostasis regulation of HIF-1-alpha;Cellular responses to external stimuli;Neddylation
(Consensus)
Recessive Scores
- pRec
- 0.154
Intolerance Scores
- loftool
- 0.849
- rvis_EVS
- -0.33
- rvis_percentile_EVS
- 30.9
Haploinsufficiency Scores
- pHI
- 0.918
- hipred
- Y
- hipred_score
- 0.701
- ghis
- 0.525
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.864
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Hif3a
- Phenotype
- muscle phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); respiratory system phenotype;
Gene ontology
- Biological process
- angiogenesis;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;apoptotic process;post-translational protein modification;positive regulation of transcription by RNA polymerase II;regulation of transcription from RNA polymerase II promoter in response to hypoxia
- Cellular component
- nucleus;nucleoplasm;mitochondrion;cytosol;plasma membrane;nuclear speck
- Molecular function
- DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein dimerization activity